Prediction of intrinsic disorder in proteins using MFDp2.
暂无分享,去创建一个
[1] K. Srivenugopal,et al. The DNA repair protein, O6-Methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein , 2002, Oncogene.
[2] A. Cuddihy,et al. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α , 1999, Oncogene.
[3] Vladimir N Uversky,et al. Intrinsic disorder in proteins associated with neurodegenerative diseases. , 2009, Frontiers in bioscience.
[4] Liam J. McGuffin,et al. The PSIPRED protein structure prediction server , 2000, Bioinform..
[5] A. Dunker,et al. Predicting intrinsic disorder in proteins: an overview , 2009, Cell Research.
[6] Jianlin Cheng,et al. A comprehensive overview of computational protein disorder prediction methods. , 2012, Molecular bioSystems.
[7] T. Kirchhausen,et al. Interaction of the Bovine Papillomavirus E6 Protein with the Clathrin Adaptor Complex AP-1 , 1998, Journal of Virology.
[8] H. Hausen. Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.
[9] I. Batty,et al. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. , 2004, The Biochemical journal.
[10] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[11] D. Lowy,et al. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture , 1991, Journal of virology.
[12] Wonhwa Cho,et al. Membrane-binding and activation mechanism of PTEN , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Dunker,et al. Abundance of intrinsic disorder in protein associated with cardiovascular disease. , 2006, Biochemistry.
[14] A. Ciechanover,et al. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Cuddihy,et al. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. , 1999, Oncogene.
[16] Lukasz A. Kurgan,et al. Improved sequence-based prediction of disordered regions with multilayer fusion of multiple information sources , 2010, Bioinform..
[17] Lukasz Kurgan,et al. RAPID: fast and accurate sequence-based prediction of intrinsic disorder content on proteomic scale. , 2013, Biochimica et biophysica acta.
[18] Miranda Thomas,et al. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins , 2000, Oncogene.
[19] Lukasz Kurgan,et al. Comprehensive comparative assessment of in-silico predictors of disordered regions. , 2012, Current protein & peptide science.
[20] Miranda Thomas,et al. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. , 1999, The Journal of general virology.
[21] D. Galloway,et al. E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc , 2001, Journal of Virology.
[22] C. Cordon-Cardo,et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Dey,et al. HPV16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence. , 1997, Virology.
[24] Ajay Mahaputra Kumar,et al. PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein* , 2000, The Journal of Biological Chemistry.
[25] X. Li,et al. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation , 1996, Journal of virology.
[26] Goberdhan P Dimri,et al. Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3 , 2002, Molecular and Cellular Biology.
[27] C. Eng,et al. Protean PTEN: form and function. , 2002, American journal of human genetics.
[28] V. Uversky,et al. Disordered interactome of human papillomavirus. , 2014, Current pharmaceutical design.
[29] Miranda Thomas,et al. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. , 1994, Oncogene.
[30] T. Gibson,et al. A careful disorderliness in the proteome: Sites for interaction and targets for future therapies , 2008, FEBS letters.
[31] A Keith Dunker,et al. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs. , 2006, Journal of proteome research.
[32] D. Patel,et al. The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300 , 1999, The EMBO journal.
[33] Lukasz Kurgan,et al. Protein intrinsic disorder as a flexible armor and a weapon of HIV-1 , 2011, Cellular and Molecular Life Sciences.
[34] Lukasz Kurgan,et al. MFDp2: Accurate predictor of disorder in proteins by fusion of disorder probabilities, content and profiles. , 2013, Intrinsically disordered proteins.
[35] Etienne Weiss,et al. Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain. , 2003, Biochemistry.
[36] P. Pandolfi,et al. Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.
[37] A. Gericke,et al. Phosphorylation keeps PTEN phosphatase closed for business , 2009, Proceedings of the National Academy of Sciences.
[38] P. Tompa,et al. Structural Disorder in Eukaryotes , 2012, PloS one.
[39] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[40] S. Cole,et al. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. , 1987, Journal of molecular biology.
[41] F. Vazquez,et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN , 2009, Proceedings of the National Academy of Sciences.
[42] M. Vidal,et al. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. , 1998, Genes & development.
[43] E. Androphy,et al. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. , 1995, Science.
[44] Jason J Chen,et al. Interaction of oncogenic papillomavirus E6 proteins with fibulin-1. , 2002, Biochemical and biophysical research communications.
[45] Yaoqi Zhou,et al. Improving the prediction accuracy of residue solvent accessibility and real‐value backbone torsion angles of proteins by guided‐learning through a two‐layer neural network , 2009, Proteins.
[46] Lukasz Kurgan,et al. More than just tails: intrinsic disorder in histone proteins. , 2012, Molecular bioSystems.
[47] Lukasz A. Kurgan,et al. In-silico prediction of disorder content using hybrid sequence representation , 2011, BMC Bioinformatics.
[48] A Keith Dunker,et al. Protein disorder in the human diseasome: unfoldomics of human genetic diseases , 2009, BMC Genomics.
[49] E. Weiss,et al. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. , 2001, Journal of molecular biology.
[50] A Keith Dunker,et al. Unfoldomics of human diseases: linking protein intrinsic disorder with diseases , 2009, BMC Genomics.
[51] J. Lefèvre,et al. Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein. , 2001, Protein expression and purification.
[52] J. S. Sodhi,et al. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. , 2004, Journal of molecular biology.
[53] Debashis Mukhopadhyay,et al. The Role of Intrinsically Unstructured Proteins in Neurodegenerative Diseases , 2009, PloS one.
[54] Miranda Thomas,et al. The role of the E6-p53 interaction in the molecular pathogenesis of HPV , 1999, Oncogene.
[55] P. Raychaudhuri,et al. Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60. , 1994, The Journal of biological chemistry.
[56] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[57] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[58] Xiaoqun Zhang,et al. Functional analysis of the protein phosphatase activity of PTEN , 2012, The Biochemical journal.
[59] Christopher J. Oldfield,et al. Intrinsically disordered proteins in human diseases: introducing the D2 concept. , 2008, Annual review of biophysics.
[60] V. Uversky. Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.
[61] L. Iakoucheva,et al. Intrinsic disorder in cell-signaling and cancer-associated proteins. , 2002, Journal of molecular biology.
[62] C. Chiang,et al. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. , 2005, Molecular cell.
[63] J. Huibregtse,et al. Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase , 2000, Molecular and Cellular Biology.
[64] T. Kanda,et al. Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein. , 1998, Biochemical and biophysical research communications.
[65] Lukasz Kurgan,et al. Genome‐scale prediction of proteins with long intrinsically disordered regions , 2014, Proteins.
[66] Helen Song,et al. The Human Papillomavirus 16 E6 Protein Binds to Tumor Necrosis Factor (TNF) R1 and Protects Cells from TNF-induced Apoptosis* , 2002, The Journal of Biological Chemistry.
[67] L. Banks,et al. Multi-PDZ Domain Protein MUPP1 Is a Cellular Target for both Adenovirus E4-ORF1 and High-Risk Papillomavirus Type 18 E6 Oncoproteins , 2000, Journal of Virology.
[68] J. Lefèvre,et al. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions. , 2000, Journal of molecular biology.
[69] Zoran Obradovic,et al. DisProt: the Database of Disordered Proteins , 2006, Nucleic Acids Res..
[70] M Fujita,et al. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[71] V. Rybin,et al. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. , 2012, Structure.
[72] Lukasz Kurgan,et al. Resilience of death: intrinsic disorder in proteins involved in the programmed cell death , 2013, Cell Death and Differentiation.
[73] Vladimir N Uversky,et al. Amyloidogenesis of natively unfolded proteins. , 2008, Current Alzheimer research.
[74] A. Dunker,et al. Orderly order in protein intrinsic disorder distribution: disorder in 3500 proteomes from viruses and the three domains of life , 2012, Journal of biomolecular structure & dynamics.
[75] Francisca Vazquez,et al. Phosphorylation of the PTEN Tail Regulates Protein Stability and Function , 2000, Molecular and Cellular Biology.
[76] Christopher J. Oldfield,et al. The unfoldomics decade: an update on intrinsically disordered proteins , 2008, BMC Genomics.
[77] V. Uversky,et al. Why are “natively unfolded” proteins unstructured under physiologic conditions? , 2000, Proteins.
[78] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[79] L. Laimins,et al. Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites , 2001, Journal of Virology.
[80] D. Gutmann,et al. Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo , 2004, Cancer Research.
[81] Pier Paolo Pandolfi,et al. Tenets of PTEN Tumor Suppression , 2008, Cell.
[82] Tomohiko Maehama,et al. Crystal Structure of the PTEN Tumor Suppressor Implications for Its Phosphoinositide Phosphatase Activity and Membrane Association , 1999, Cell.
[83] Kai Wang,et al. Incorporating background frequency improves entropy-based residue conservation measures , 2006, BMC Bioinform..
[84] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[85] M. O’Connor,et al. The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300 , 1999, Journal of Virology.